Publications

The Annals of pharmacotherapy

Cyclosporine-induced anaphylaxis.

06-08-2000

PDA journal of pharmaceutical science and technology

Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidine.

06-08-2000

Nederlands tijdschrift voor geneeskunde

[Second primary tumors in patients treated at an early age for Hodgkin's disease; consequences for the follow-up].

05-08-2000

British journal of cancer

Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export.

01-08-2000

Investigational new drugs

The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery.

01-08-2000

Anti-cancer drugs

The clinical pharmacology of alkylating agents in high-dose chemotherapy.

01-08-2000

Cancer chemotherapy and pharmacology

Feasibility and pharmacokinetics of intraperitoneal suramin in advanced malignancy.

27-07-2000

The Journal of cell biology

Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology.

10-07-2000

Cell

Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage.

07-07-2000

Oncogene

A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts.

06-07-2000

Cell and tissue research

Radiation-induced apoptosis.

01-07-2000

Molecular and biochemical parasitology

Tandemly repeated DNA is a target for the partial replacement of thymine by beta-D-glucosyl-hydroxymethyluracil in Trypanosoma brucei.

01-07-2000

Proceedings of the National Academy of Sciences of the United States of America

Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs.

20-06-2000

American journal of epidemiology

Reporting bias in case-control studies on induced abortion and breast cancer.

15-06-2000

British journal of clinical pharmacology

Evaluation of the autoinduction of ifosfamide metabolism by a population pharmacokinetic approach using NONMEM.

01-06-2000

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Phase I and pharmacokinetic study of oral paclitaxel.

01-06-2000

Patient education and counseling

Psychological distress two years after diagnosis of breast cancer: frequency and prediction.

01-06-2000

Clinical pharmacology and therapeutics

Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods.

01-06-2000

The Journal of cell biology

The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin alpha6beta4 and may regulate the spatial organization of hemidesmosomes.

15-05-2000

Cancer chemotherapy and pharmacology

Successful treatment with paclitaxel of a patient with metastatic extra-adrenal pheochromocytoma (paraganglioma). A case report and review of the literature.

10-05-2000

International journal of radiation biology

Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations.

01-05-2000

European journal of immunology

Tumor size at the time of adoptive transfer determines whether tumor rejection occurs.

01-05-2000

European journal of immunology

Tracing and characterization of the low-avidity self-specific T cell repertoire.

01-05-2000

Genes & development

Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum.

15-04-2000

Cancer causes & control : CCC

Cancer risk associated with subfertility and ovulation induction: a review.

01-04-2000

Anti-cancer drugs

Docetaxel in 253 previously treated patients with progressive locally advanced or metastatic breast cancer: results of a compassionate use program in The Netherlands.

01-04-2000

Cancer journal (Sudbury, Mass.)

High-dose chemotherapy with peripheral blood progenitor cell transplantation in the adjuvant treatment of breast cancer.

01-04-2000

Oncogene

The adenovirus E1A binding protein BS69 is a corepressor of transcription through recruitment of N-CoR.

16-03-2000

International journal of radiation oncology, biology, physics

A treatment planning method to correct dose distributions distorted by setup verification fields.

15-03-2000

The cancer journal from Scientific American

Translational research offers individually tailored treatments for cancer patients.

04-03-2000

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

The bactericidal/permeability-increasing protein (BPI) is membrane-associated in azurophil granules of human neutrophils, and relocation occurs upon cellular activation.

01-03-2000

Drug metabolism and disposition: the biological fate of chemicals

The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice.

01-03-2000

Journal of cell science

Formation of hemidesmosome-like structures in the absence of ligand binding by the (alpha)6(beta)4 integrin requires binding of HD1/plectin to the cytoplasmic domain of the (beta)4 integrin subunit.

01-03-2000

Cancer chemotherapy and pharmacology

Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion.

09-02-2000

The Journal of clinical investigation

Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.

01-02-2000

Fresenius' journal of analytical chemistry

Validated method for the determination of platinum from a liposomal source (SPI-77) in human plasma using graphite furnace Zeeman atomic absorption spectrometry.

01-02-2000

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.

01-02-2000

American journal of human genetics

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

01-02-2000

International journal of pharmaceutics

In vitro biocompatibility studies with the experimental anticancer agent BIBX1382BS.

25-01-2000

Journal of the National Cancer Institute

Physical activity and breast cancer risk in women aged 20-54 years.

19-01-2000

The Journal of cell biology

Induction of cell scattering by expression of beta1 integrins in beta1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function.

13-12-1999

Journal of cell science

Chromatin-association of the Polycomb group protein BMI1 is cell cycle-regulated and correlates with its phosphorylation status.

01-12-1999

The EMBO journal

The modified base J is the target for a novel DNA-binding protein in kinetoplastid protozoans.

15-11-1999

Investigational new drugs

Pharmacokinetics and metabolism of the staurosporine analogue CGP 41 251 in mice.

11-11-1999

Analytical biochemistry

32P-postlabeling assay for the quantification of the major platinum-DNA adducts.

01-11-1999

The Journal of clinical investigation

Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure.

01-11-1999

Clinical cancer research : an official journal of the American Association for Cancer Research

Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.

01-11-1999

Anti-cancer drugs

Compatibility and stability of aplidine, a novel marine-derived depsipeptide antitumor agent, in infusion devices, and its hemolytic and precipitation potential upon i.v. administration.

01-11-1999

International journal of radiation oncology, biology, physics

Dose-wall histograms and normalized dose-surface histograms for the rectum: a new method to analyze the dose distribution over the rectum in conformal radiotherapy.

01-11-1999

Journal of cell science

Partial rescue of epithelial phenotype in integrin beta4 null mice by a keratin-5 promoter driven human integrin beta4 transgene.

01-11-1999

Cyclosporine-induced anaphylaxis.

Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidine.

[Second primary tumors in patients treated at an early age for Hodgkin's disease; consequences for the follow-up].

Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export.

The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery.

The clinical pharmacology of alkylating agents in high-dose chemotherapy.

Feasibility and pharmacokinetics of intraperitoneal suramin in advanced malignancy.

Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology.

Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage.

A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts.

Radiation-induced apoptosis.

Tandemly repeated DNA is a target for the partial replacement of thymine by beta-D-glucosyl-hydroxymethyluracil in Trypanosoma brucei.

Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs.

Reporting bias in case-control studies on induced abortion and breast cancer.

Evaluation of the autoinduction of ifosfamide metabolism by a population pharmacokinetic approach using NONMEM.

Phase I and pharmacokinetic study of oral paclitaxel.

Psychological distress two years after diagnosis of breast cancer: frequency and prediction.

Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods.

The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin alpha6beta4 and may regulate the spatial organization of hemidesmosomes.

Successful treatment with paclitaxel of a patient with metastatic extra-adrenal pheochromocytoma (paraganglioma). A case report and review of the literature.

Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations.

Tumor size at the time of adoptive transfer determines whether tumor rejection occurs.

Tracing and characterization of the low-avidity self-specific T cell repertoire.

Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum.

Cancer risk associated with subfertility and ovulation induction: a review.

Docetaxel in 253 previously treated patients with progressive locally advanced or metastatic breast cancer: results of a compassionate use program in The Netherlands.

High-dose chemotherapy with peripheral blood progenitor cell transplantation in the adjuvant treatment of breast cancer.

The adenovirus E1A binding protein BS69 is a corepressor of transcription through recruitment of N-CoR.

A treatment planning method to correct dose distributions distorted by setup verification fields.

Translational research offers individually tailored treatments for cancer patients.

The bactericidal/permeability-increasing protein (BPI) is membrane-associated in azurophil granules of human neutrophils, and relocation occurs upon cellular activation.

The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice.

Formation of hemidesmosome-like structures in the absence of ligand binding by the (alpha)6(beta)4 integrin requires binding of HD1/plectin to the cytoplasmic domain of the (beta)4 integrin subunit.

Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion.

Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.

Validated method for the determination of platinum from a liposomal source (SPI-77) in human plasma using graphite furnace Zeeman atomic absorption spectrometry.

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

In vitro biocompatibility studies with the experimental anticancer agent BIBX1382BS.

Physical activity and breast cancer risk in women aged 20-54 years.

Induction of cell scattering by expression of beta1 integrins in beta1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function.

Chromatin-association of the Polycomb group protein BMI1 is cell cycle-regulated and correlates with its phosphorylation status.

The modified base J is the target for a novel DNA-binding protein in kinetoplastid protozoans.

Pharmacokinetics and metabolism of the staurosporine analogue CGP 41 251 in mice.

32P-postlabeling assay for the quantification of the major platinum-DNA adducts.

Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure.

Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.

Compatibility and stability of aplidine, a novel marine-derived depsipeptide antitumor agent, in infusion devices, and its hemolytic and precipitation potential upon i.v. administration.

Dose-wall histograms and normalized dose-surface histograms for the rectum: a new method to analyze the dose distribution over the rectum in conformal radiotherapy.

Partial rescue of epithelial phenotype in integrin beta4 null mice by a keratin-5 promoter driven human integrin beta4 transgene.

This site uses cookies